Andlauer Healthcare Group Inc.
AND.TO · TSX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | CA$2,059,787 | CA$1,570,842 | CA$1,656,392 | CA$1,536,210 |
| - Cash | CA$58,981 | CA$44,103 | CA$40,483 | CA$35,994 |
| + Debt | CA$178,141 | CA$182,597 | CA$181,210 | CA$158,973 |
| Enterprise Value | CA$2,178,947 | CA$1,709,336 | CA$1,797,119 | CA$1,659,189 |
| Revenue | CA$156,602 | CA$166,088 | CA$168,293 | CA$159,600 |
| % Growth | -5.7% | -1.3% | 5.4% | – |
| Gross Profit | CA$35,795 | CA$36,749 | CA$39,500 | CA$37,229 |
| % Margin | 22.9% | 22.1% | 23.5% | 23.3% |
| EBITDA | CA$38,410 | CA$45,341 | CA$43,832 | CA$41,814 |
| % Margin | 24.5% | 27.3% | 26% | 26.2% |
| Net Income | CA$13,450 | CA$20,225 | CA$17,528 | CA$16,286 |
| % Margin | 8.6% | 12.2% | 10.4% | 10.2% |
| EPS Diluted | 0.34 | 0.5 | 0.44 | 0.41 |
| % Growth | -32% | 13.6% | 7.3% | – |
| Operating Cash Flow | CA$35,920 | CA$33,037 | CA$22,625 | CA$30,665 |
| Capital Expenditures | -CA$5,293 | -CA$7,463 | -CA$5,005 | -CA$4,164 |
| Free Cash Flow | CA$30,627 | CA$25,574 | CA$17,620 | CA$26,501 |